Rock Springs Capital Management LP Kura Oncology, Inc. Transaction History

Rock Springs Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$12.22 - $19.57 $10.1 Million - $16.1 Million	-822,500 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$15.42 - $21.72 $87,894 - $123,804	5,700 Added 0.7%	822,500 $15.4 Million
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $2.23 Million - $3.19 Million	106,765 Added 15.04%	816,800 $17 Million
Q1 2021 May 17, 2021	BUY	$24.75 - $39.14 $5 Million - $7.9 Million	201,919 Added 39.74%	710,035 $20.1 Million
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $14.7 Million - $21.1 Million	508,116 New	508,116 $16.6 Million
Q4 2018 Feb 14, 2019	SELL	$10.6 - $17.49 $4.29 Million - $7.08 Million	-405,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.65 - $21.85 $83,250 - $109,250	5,000 Added 1.25%	405,000 $7.09 Million
Q2 2018 Aug 14, 2018	BUY	$14.8 - $18.8 $5.53 Million - $7.02 Million	373,500 Added 1409.43%	400,000 $7.28 Million
Q1 2018 May 15, 2018	BUY	$14.5 - $23.4 $384,250 - $620,100	26,500 New	26,500 $497,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.